baber/WOPTO huggingface dataset:
Patent CA-2651402-C (CA)
Inventor: URSIN VIRGINIA
IPC: A23L29/20
Filed: 2007-07-18
Granted: 2016-04-05
Abstract: The invention relates generally to methods and compositions concerning desaturase enzymes that modulate the number and location of double bonds in long chain poly-unsaturated fatty acids (LC-PUFA's). In particular, the invention relates to methods and compositions for improving omega-3 fatty acid profiles in plant products and parts using desaturase enzymes and nucleic acids encoding for such enzymes. In particular embodiments, the desaturase enzymes are Tetraselmis suecica delta 6 desaturases. Also provided are improved soybean oil compositions having GLA and SDA.
Patent CA-2656708-C (CA)
Title: Liquid food dispenser system and method
Inventor: DOELMAN TIMOTHY PETER
IPC: B67D7/36
Filed: 2007-07-06
Granted: 2015-05-19
Abstract: A system and method for dispensing fluids is introduced. A preferred embodiment comprises a sealed tank, a bag containing fluid inside the sealed tank, an outlet for dispensing the liquid in the bag, and a pressure generating device to create pressure in the sealed tank.
Patent CA-2657196-C (CA)
Title: Transport dwdm de signaux de television par cable et de signaux numeriques par fibre optique dans des regions spectrales de faible
Inventor: MOSTERT WILLEM A
IPC: H04J14/02
Filed: 2007-06-04
Granted: 2013-10-08
Abstract: Les procédés et appareils décrits concernent le transport DWDM de signaux de télévision par câble et de signaux numériques par fibre optique dans des régions spectrales de faible dispersion. Un procédé consiste à transporter une pluralité de porteuses optiques de différentes longueurs d'onde sur une liaison optique utilisant le multiplexage par répartition en longueur d'onde, la liaison optique comprenant une pluralité de segments optiques. La pluralité de longueurs d'onde centrales du canal optique définies par la pluralité de porteuses optiques sont groupées à proximité de la valeur moyenne d'une longueur d'onde de dispersion nulle de la liaison optique, ou à proximité soit a) d'une frange à basse longueur d'onde, soit b) d'une frange à haute longueur d'onde d'une plage de longueurs d'onde de dispersion nulle de la liaison optique et une pluralité de fréquences centrales du canal optique définies par la pluralité de longueurs d'onde centrales du canal optique sont espacées les unes des autres de façon non uniforme.
Patent CA-2657491-C (CA)
Title: Vaccines
Inventor: DALTON COLIN CLIVE
IPC: A61B17/20
Filed: 2001-07-18
Granted: 2012-03-06
Abstract: The present invention relates to efficient devices for administration of pharmaceutical agents into the skin of the human body. In particular the present invention provides devices for vaccination into the skin. The present invention provides a pharmaceutical agent delivery device having skin-piercing portion comprising a solid reservoir medium containing the pharmaceutical agent, wherein the reservoir medium is coated onto the skin piercing portion. alternatively, the skin piercing portion may consist of the solid pharmaceutical agent reservoir medium. The pharmaceutical delivery devices are proportioned such that agent is delivered into defined layers of the skin, and preferred delivery devices comprise skin-piercing portions that deliver the pharmaceutical agent into the epithelium or the dermis. Preferred reservoir media comprise sugars, and in particular stabilising sugars that forms a glass such as lactose, raffinose, trehalose or sucrose. Furthermore, vaccine delivery devices for administration of vaccines into the skin are provided, methods of their manufacture, and their use in medicine.
Patent CA-2659848-C (CA)
Inventor: HARTLEY DAVID ERNEST
IPC: A61F2/04
Filed: 2007-08-20
Granted: 2015-10-06
Abstract: A stent graft has a tubular body of a biocompatible material and at least two fenestrations. The at least two fenestrations are adjacent each other and each has a tube extending into the tubular body. The tubes are joined inside the tubular body into a single larger tube to facilitate catheterization.
Patent CA-2669012-C (CA)
Title: Combinaisons d'edelfosine et d'agents anti-cancer pour le traitement du cancer
Inventor: KHAZAK VLADIMIR
IPC: G01N33/50
Filed: 2007-11-09
Granted: 2017-06-20
Abstract: L'invention concerne un procédé permettant de déterminer l'utilité de petites molécules en tant que substituts fonctionnels (mimétiques) pour des ligands de récepteurs protéiques. Le procédé repose sur l'utilisation d'essais biologiques cellulaires sur un réseau systématique de composés, comprenant des ligands connus de récepteurs protéiques et d'autres molécules biologiquement actives, pour déterminer si une petite molécule proposée est un équivalent fonctionnel d'un ligand de récepteur et présente une utilité thérapeutique en tant qu'agent pharmaceutiquement approprié et utile, soit seule, soit en combinaison avec d'autres molécules.
Patent CA-2669652-C (CA)
Inventor: SURINENI SHRAVAN K
IPC: H04J99/00
Filed: 2007-11-15
Granted: 2013-12-10
Abstract: Systems and methodologies are described that facilitate coordinating and conducting transmissions to multiple stations in a wireless communication system during a single transmission opportunity. A holder of a transmission opportunity can communicate a request-to-send message or a self-addressed clear-to-send message to one or more stations to establish the transmission opportunity. Subsequently, data transmissions with respective stations can be initiated by transmitting request-to-send messages to the respective stations. At each receiving station, the source address of a received request-to-send message is compared to the address of the holder of the transmission opportunity. If the addresses match for a given request-to-send message, the receiving station transmits a clear-to-send message to the holder of the transmission opportunity in response to the request-to-send message.
Patent CA-2672284-C (CA)
Title: Human growth hormone formulations
Inventor: CHUNG WEN-LI
IPC: A61K9/10
Filed: 2007-12-13
Granted: 2014-08-26
Abstract: Formulations containing complexed human growth hormone crystals are described. Also described are needleless injection systems for crystalline proteins.
Patent CA-2672866-C (CA)
Inventor: BAUGH BENTON F
IPC: E02D27/35
Filed: 2004-04-08
Granted: 2013-03-12
Abstract: The instant disclosure relates to a system and method of constructing drilling and production platforms that are particularly useful in remote, inaccessible and/or environmentally sensitive operating environments. According to one aspect of the invention, an arctic drilling platform is provided wherein various methods and means of interlocking neighboring platform modules are provided Methods and means for sealing the intersections formed between a plurality of interlocked platform modules are also disclosed. According to further aspects of the invention, improved platform floor plans are provided, and various wellhead cellar layouts and sealing means are also described. Methods and means of enhancing the usefulness of modular storage platforms are disclosed, and a number of support post installation and removal techniques are also provided. Also taught are a variety of methods of adjusting the height and level of an assembled drilling platform, and methods and means of adding extension members useful for extending the length of a support post are also described.
Patent CA-2674803-C (CA)
Title: Quinazoline derivatives as angiogenesis inhibitors
Inventor: STOKES ELAINE SOPHIE ELIZABETH
IPC: A61P13/00
Filed: 2000-02-08
Granted: 2012-10-09
Abstract: The invention relates to the use of compounds of formula (I) (see formula I) wherein ring C is an 8, 9, 10, 12 or 13-membered bicyclic or tricyclic moiety which optionally may contain 1-3 heteroatoms selected independently from O, N and S; Z is -O-, -NH-, -S-, -CH2- or a direct bond; n is 0-5; m is 0-3; R2 represents hydrogen, hydroxy, halogeno, cyano, nitro, trifluoromethyl, C1-3alkyl, C1- 3alkoxy, C1-3alkylsulphanyl, -NR3R4 (wherein R3 and R4, which may be the same or different, each represents hydrogen or C1-3alkyl), or R5X1- (wherein X1 and R5 are as defined herein; R1 represents hydrogen, oxo, halogeno, hydroxy, C1-4alkoxy, C1-4alkyl, C1-4alkoxymethyl, C14alkanoyl, C1-4haloalkyl, cyano, amino, C2- 5alkenyl, C2-5alkynyl, C1-3alkanoyloxy, nitro, C1-4alkanoylamino, C1-4alkoxycarbonyl, C1-4alkylsulphanyl, C1-4alkylsulphinyl, C1-4alkylsulphonyl, carbamoyl, N-C1-4alkylcarbamoyl, N,N-di(C1-4alkyl)carbamoyl, aminosulphonyl, N-C1-4alkylaminosulphonyl, N,N-di(C1-4alkyl)aminosulphonyl, N-(C1-4alkylsulphonyl)amino, N-(C1-4alkylsulphonyl)-N-(C1-4alkyl)amino, N,N-di(C1-4alkylsulphonyl)amino, a C3-7alkylene chain joined to two ring C carbon atoms, C1-4alkanoylaminoC1-4alkyl, carboxy or a group R56X10 (wherein X10 and R56. are as defined herein); and salts thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals, processes for the preparation of such compounds, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient and compounds of formula (I). The compounds of formula (I) and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent CA-2675452-C (CA)
Inventor: DOBROWSKI PATRICK M
IPC: H04L45/28
Filed: 2007-01-11
Granted: 2015-11-24
Abstract: A control system uses a wireless network to provide communication between a host computer and field devices. The host and the field devices communicate with one another using control messages and response messages based upon a known control system protocol. The control and response messages are embedded as a payload within a wireless message that is transmitted over the wireless network. When the wireless message is received at its ultimate destination, the control or response message is separated from the wireless message and is delivered to the intended recipient (either a field device or the host computer).
Patent CA-2679509-C (CA)
Title: A method and apparatus for configuring compressed mode
Inventor: FARNSWORTH ANDREW
IPC: H04W24/00
Filed: 2009-09-21
Granted: 2014-08-05
Abstract: A method and apparatus for configuring compressed mode operation comprises detecting a compressed mode pattern or pattern sequence scheduling three or more consecutive compressed mode frames and taking appropriate mitigation action. In a first aspect a non activation construction is suppressed and the compressed mode pattern sequence is activated. In the second aspect if a pattern or sequence scheduling three or more consecutive compressed mode frames is identified, activation is suppressed. In a third aspect if such a patent or sequence is identified, a normal frame is inserted in the pattern sequence replacing a compressed mode frame.
Patent CA-2687046-C (CA)
Title: Hazard detection and suppression apparatus
Inventor: EDWARDS RICHARD H
IPC: F16K17/16
Filed: 2008-05-12
Granted: 2012-01-10
Abstract: A hazard detection and suppression apparatus and a single-action discharge valve for discharging a vessel's contents. The valve has a valve body with a passage therethrough through which the contents are discharged, a frangible seal held within the valve body and sealing the passage while the seal is intact, and a solenoid including an armature moveable from a first to a second position. A thermopile or a thermopile matrix senses near-infrared energy to detect a fire hazard and actuate the valve. Amplifiers for the thermopile's signal are monitored for failure. A thermostat or a manual pushbutton can also actuate the valve, and an operator's panel monitors failure conditions. Other hazard detectors may be used including a petroleum detector, a chemical sensor, a moisture detector, a radiation detector, a gas detector, and a moving body detector.
Patent CA-2697774-C (CA)
Inventor: NARDEO MAHASE
IPC: A61M39/06
Filed: 2008-09-17
Granted: 2016-04-05
Abstract: A tearaway sheath assembly (100) having a splittable sheath tube (102) a splittable hub (110), a split valve (150, 250) and a split cap (180). The valve (150, 250) has a slit (158, 258) at least partially across the transverse distal section (154) such that transverse distal section may be displaced laterally during insertion through the slit (158, 258), of a dilator (200) or a catheter. The valve (150, 250) is formed in two separate halves (152A, 152B; 252) that are fused or adhered to each other to form a sealed weak bond (154) that is easily broken during splitting of the sheath; each valve half is mechanically affixed in a proximal valve-receiving recess (130) of the hub such as by anchor posts (136) extending through apertures (166A, 166B) in ears (164A, 164B) of each valve half. A two-part cap (180) is affixed to the hub proximal end (120) and traps the valve between itself and the hub. Pairs of opposed gaps (184, 122) of the cap (180) and the hub (110) are aligned with lines of weakness or seams (106) of the sheath tube (102) and the weak bond (154) of the valve, facilitating splitting of the assembly (100) when desired by the practitioner to peel it away from the inserted catheter.
Patent CA-2698382-C (CA)
Inventor: COMEAU MICHAEL R
IPC: C07K16/24
Filed: 2008-09-09
Granted: 2015-07-14
Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins which bind to human thymic stromal lymphopoietin (TSLP), including antibodies. In particular embodiments, the disclosure provides fully human, humanized and chimeric anti-TSLP antibodies and derivatives of such antibodies. The disclosure further provides nucleic acids encoding such antibodies and antibody fragments and derivatives, and methods of making and using such antibodies including methods of treating and preventing TSLP-related inflammatory and fibrotic disorders.
Patent CA-2699818-C (CA)
Title: Porte isolee et sa methode de fabrication
Inventor: STRICKLAND BOBBY NEAL
IPC: E06B5/16
Filed: 2010-04-12
Granted: 2013-06-11
Abstract: Une porte isolée comprenant une coque de porte ayant des premier et second panneaux extérieurs espacés. La porte comprend une pluralité de raidisseurs liés à un panneau de garniture, avec une isolation thermique entre les raidisseurs adjacents, disposés à l'intérieur de la coque de porte. Le panneau de garniture peut s'étendre le long d'un côté des raidisseurs et l'isolation thermique le long du panneau de garniture entre les raidisseurs et les premier et second panneaux extérieurs. Les raidisseurs et le panneau de garniture sont de préférence en acier et les raidisseurs sont soudés au panneau de garniture. Les raidisseurs ne sont de préférence pas soudés aux premier et second panneaux extérieurs de la coque de porte. Le panneau de garniture est de préférence inséré dans le premier ou le second panneau extérieur de la coque de porte. Le matériau isolant remplit sensiblement tout l'espace entre le panneau de garniture et l'un des premier ou second panneaux extérieurs.
Patent CA-2699881-C (CA)
Inventor: LE GALLO PATRICK
IPC: H01M8/04007
Filed: 2008-09-23
Granted: 2017-01-03
Abstract: The invention relates to an electrolyser including a stack of a plurality of elementary electrolysis cells (C1, C2), each cell (C1, C2) including a cathode (2.1, 2.2), an anode (4.1, 4.2) and an electrolyte (6.1, 6.2) provided between the cathode (2.1, 2.2) and the anode (4.1, 4.2), an interconnection plate (8) provided between each anode (4.1) of an elementary cell (C1) and a cathode (2.2) of a following elementary cell (C2), said interconnection plate (8) being in electric contact with the anode (4.1) and the cathode (2.2), wherein steam is to be brought into contact with the cathodes, and wherein the electrolyser includes means capable of ensuring the flow of steam in the electrolyser for heating it up before contacting the same with the cathodes.
Patent CA-2702386-C (CA)
Title: Improved methods of producing rpe cells and compositions of rpe cells
Inventor: MALCUIT CHRISTOPHER
IPC: C12N5/071
Filed: 2008-10-10
Granted: 2018-07-24
Abstract: The present invention provides improved methods for producing RPE cells from human embryonic stem cells or from other human pluripotent stem cells. The invention also relates to human retinal pigmented epithelial cells derived from human embryonic stem cells or other human multipotent or pluripotent stem cells.  hRPE cells derived from embryonic stem cells are molecularly distinct from adult and fetal-derived RPE cells, and are also distinct from embryonic stem cells. The hRPE cells described herein are useful for treating retinal degenerative diseases.
Patent CA-2710451-C (CA)
Inventor: MASSON RICHARD
IPC: C22C47/06
Filed: 2008-12-24
Granted: 2016-12-20
Abstract: A process for manufacturing a metal part reinforced with ceramic fibers, in which: a housing is formed for an insert in a main metal body having an upper face; an insert formed from a bundle of fibers with a metal matrix is placed in the housing; a metal cover is placed on the main body so as to cover the insert; the cover is welded onto the metal body; a hot isostatic pressing operation is carried out; and the part obtained is machined to the desired shape. The housing has the shape of a notch of L-shaped cross section with a face perpendicular to the upper face and a face parallel to the upper face, the cover having an internal notch of L-shaped cross section, this having a shape complementary to that of the metal body with said insert, the cover being shaped on the outside so that the pressure forces are exerted perpendicular to said faces of the notch.
Patent CA-2712496-C (CA)
Title: Stem cell aggregates and methods for making and using
Inventor: HU WEI-SHOU
IPC: C12Q1/02
Filed: 2009-01-21
Granted: 2021-01-12
Abstract: The invention is directed to compositions of cell aggregates and methods for making and using the cell aggregates where the aggregates comprise cells that are not embryonic stem cells but can differentiate into cell types of at least two of ectodermal, undo dermal, and mesodermal embryonic germ layers, e.g., stem cells.
Patent CA-2723848-C (CA)
Inventor: GAMMELSAETER RUNHILD
IPC: A61K35/65
Filed: 2009-05-07
Granted: 2013-01-08
Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. This invention relates to the use of cells and cellular extracts in rejuvenation and healing technologies thereby improving healing and regeneration of all bodily tissues and organs. The present invention relates to compositions and methods of managing, preventing, and treating scars. The invention also relates to prevention of deterioration, damage and malfunction of cells and tissues, and to promote, improve or exceed cellular function in order to promote, improve and exceed appearance, vitality and health. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products.
Patent CA-2730414-C (CA)
Inventor: MITCHELL STEVEN A
IPC: E04C2/40
Filed: 2011-01-28
Granted: 2014-10-21
Abstract: Un système de panneaux comprend des panneaux allongés assemblés à une portion de jonction comportant des portions d'interblocage respectives aux extrémités verticales correspondantes pour présenter une surface substantiellement plane. Dans les systèmes de panneaux coulissants, les panneaux coulissants joints comportent des rangées disposées verticalement qui permettent l'assemblage le long des rebords horizontaux adjacents des rangées respectives des panneaux coulissants.
Patent CA-2733210-C (CA)
Title: Oral cancer screening device
Inventor: ZULUAGA ANDRES FELIPE
IPC: A61B1/24
Filed: 2009-05-07
Granted: 2014-08-12
Abstract: An oral cancer screening device (10) used for the detection of pre-cancerous and cancerous tissue has a power sup-ply (100), an illumination source (200), a selector switch (300) that enables the activation of a specific wavelength of light from the illumination source (200), an electrical system (400) in communication with the selector switch (300) and the illumination source (200), a heat sink (500) in thermal communication with the illumination source, a filter or cover (600) to protect the illumi-nation source, and a transparent sheath (700) for providing a sanitary shield for the device when it is brought into contact or close proximity with the patient oral cavity. The sheath may optionally have an angled mirror incorporated at a distal end of the sheath to provide the operator with a reflected image of the illuminated tissue (900). The operator will optionally utilize head mounted lenses (800) to assist the operator's visualization of the light from the illuminated oral cavity.
Patent CA-2737789-C (CA)
Title: Grease removal apparatus, systems and methods
Inventor: ALEXANDER GLENN DAVID
IPC: F24C15/20
Filed: 2009-09-23
Granted: 2017-10-17
Abstract: A filter assembly includes a filter pad comprising fibers including natural, synthetic and/or hybrid fibers. A stabilizer frame formed of a non-metallic material may be imbedded in the filter pad. The stabilizer frame may be configured to provide support to the filter pad to maintain the filter pad in a generally flat configuration. In accordance with a particular embodiment, the filter pad may be comprised of at least first and second fibrous mats that are coupled together. In this embodiment, the stabilizer frame may be disposed between and coupled with the first and second fibrous mats.
Patent CA-2738709-C (CA)
Inventor: KUHN PETER
IPC: A61M39/20
Filed: 2008-09-29
Granted: 2014-05-27
Abstract: The invention relates to a tip cap assembly for closing a distal opening of a receptacle like a syringe body or a tube in a sealed manner, and to a method for producing the tip cap. A cap assembly according to the invention comprises a frangible tip of a receptacle, preferably a pre-filled receptacle. An upper portion of the tip closes the receptacle respectively a lower tip portion comprising a passage as known from the state of the art. Hence, the receptacle is reliably sealed to prevent contamination or loss of the medication. Compared with the state of the art, a receptacle has a more effectively sealed tip. It is necessary to break the upper tip portion away in order to open the receptacle. A cap element protects the tip on one side. On the other side, unscrewing the cap breaks the upper portion away without hurting a person.
Patent CA-2740904-C (CA)
Inventor: VARADI KATALIN
IPC: G01N33/542
Filed: 2009-10-20
Granted: 2019-01-15
Abstract: The invention relates to the development of in vitro assay systems that force the release of a water-soluble polymer, such as polyethylene glycol (PEG) and polysialic acid (PSA), from proteins modified with a reversibly-linked water-soluble polymer. The invention includes methods for analyzing the release of the water-soluble polymer and measuring regained protein activity. The invention further includes methods appropriate for the quality control of proteins modified with releasable water-soluble polymers, including polymers like PEG and PSA.
Patent CA-2741682-C (CA)
Inventor: ORBAN JACQUES
IPC: E21B49/06
Filed: 2008-10-31
Granted: 2016-06-14
Abstract: A system for coring an underground formation surrounding a borehole, comprising: a tool body that can be positioned in the borehole near the formation to be cored, the tool body including a motor; a rotary drive head connected to the motor; a rotary tool connected to the rotary drive head and one end and carrying a drill bit at the other end; a drive mechanism including an operable anchor for anchoring in the borehole and an axial drive for advancing tool body and the rotary tool; and a guide for urging the rotary tool laterally from the borehole into the surrounding formation; wherein the rotary tool is a tubular coring tool conveying an annular drill bit.